ArticleOncology reports2024

Antitumor activities of anti‑CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer.

Kenichiro Ishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.